Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Phase II
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Phase II
EMA issues advice on casirivimab and imdevimab antibody cocktail for the…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase II
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Clinical
Incyte Announces the Validation by the European Medicines Agency of its…
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Abcam to Report Interim Results on Monday, March 8, 2021
Phase II
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Home
Clinical
Phase II
Phase II
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase II
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient self-testing using nasal swabs in Germany Swiss Stock Exchange:RO
Globenewswire News
-
February 26, 2021
Phase II
EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19 Swiss Stock Exchange:RO
Phase II
Daiichi Sankyo and LYSA-LYSARC-CALYM Enter Research Collaboration for Valemetostat in Patients with Relapsed/Refractory B-Cell Lymphoma – FirstWord Pharma
Phase II
Vicore Pharma Holding AB (publ) publishes the year-end report for 2020
Phase II
MediWound Reports Fourth Quarter and Full-Year 2020 Financial Results
Phase II
Galecto Appoints Anne Prener to its Board of Directors
Biospace News
-
January 8, 2021
0
Phase II
Zydus Cadila submits Phase I/II clinical trial data of ZyCoV-D, seeks...
Firstwordpharma News
-
December 25, 2020
0
Phase II
High-Dose Quadrivalent Influenza Vaccine Shows Favourable Phase 2 Trial Results in...
Firstwordpharma News
-
October 31, 2020
0
Phase II
Idera Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update...
Globenewswire News
-
October 29, 2020
0
Phase II
Brazil governor says health regulator will not be pressured over coronavirus...
Firstwordpharma News
-
October 25, 2020
0
1
2
3
...
35
Page 1 of 35
- Advertisement -
MOST POPULAR
Failed studies prompt Lundbeck to terminate foliglurax in Parkinson’s disease, Lu...
March 29, 2020
3DBio Therapeutics Receives Orphan Drug Designation for AuriNovo for Ear Reconstruction...
November 19, 2019
BriaCell Announces C$500,000 Equity Investment by BriaCell Director
February 26, 2019
Gene editing therapy may reverse ageing: Study ...
February 20, 2019
Load more
HOT NEWS
Deals
Atreca Announces Strategic Research Collaboration with Merck to Identify Novel Antibody...
Others
Scottish Medicines Consortium dasatinib (Sprycel)
Commercial
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2018 Financial Results
Deals
Targovax and IOVaxis Therapeutics Enters Option Agreement for TG Mutant RAS...
